199 related articles for article (PubMed ID: 25743748)
41. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
42. Screening for Ames mutagenicity of food flavor chemicals by (quantitative) structure-activity relationship.
Honma M; Kitazawa A; Kasamatsu T; Sugiyama KI
Genes Environ; 2020 Nov; 42(1):32. PubMed ID: 33292765
[TBL] [Abstract][Full Text] [Related]
43. (Q)SAR assessments of potentially mutagenic impurities: a regulatory perspective on the utility of expert knowledge and data submission.
Powley MW
Regul Toxicol Pharmacol; 2015 Mar; 71(2):295-300. PubMed ID: 25545315
[TBL] [Abstract][Full Text] [Related]
44. Non-animal photosafety assessment approaches for cosmetics based on the photochemical and photobiochemical properties.
Onoue S; Suzuki G; Kato M; Hirota M; Nishida H; Kitagaki M; Kouzuki H; Yamada S
Toxicol In Vitro; 2013 Dec; 27(8):2316-24. PubMed ID: 24134854
[TBL] [Abstract][Full Text] [Related]
45. Development of QSAR models using artificial neural network analysis for risk assessment of repeated-dose, reproductive, and developmental toxicities of cosmetic ingredients.
Hisaki T; Aiba Née Kaneko M; Yamaguchi M; Sasa H; Kouzuki H
J Toxicol Sci; 2015 Apr; 40(2):163-80. PubMed ID: 25786522
[TBL] [Abstract][Full Text] [Related]
46. Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity.
Ahlberg E; Amberg A; Beilke LD; Bower D; Cross KP; Custer L; Ford KA; Van Gompel J; Harvey J; Honma M; Jolly R; Joossens E; Kemper RA; Kenyon M; Kruhlak N; Kuhnke L; Leavitt P; Naven R; Neilan C; Quigley DP; Shuey D; Spirkl HP; Stavitskaya L; Teasdale A; White A; Wichard J; Zwickl C; Myatt GJ
Regul Toxicol Pharmacol; 2016 Jun; 77():1-12. PubMed ID: 26879463
[TBL] [Abstract][Full Text] [Related]
47. Use of read-across and computer-based predictive analysis for the safety assessment of PEG cocamines.
Skare JA; Blackburn K; Wu S; Re TA; Duche D; Ringeissen S; Bjerke DL; Srinivasan V; Eisenmann C
Regul Toxicol Pharmacol; 2015 Apr; 71(3):515-28. PubMed ID: 25659490
[TBL] [Abstract][Full Text] [Related]
48. Characterization and validation of an in silico toxicology model to predict the mutagenic potential of drug impurities.
Valerio LG; Cross KP
Toxicol Appl Pharmacol; 2012 May; 260(3):209-21. PubMed ID: 22426359
[TBL] [Abstract][Full Text] [Related]
49. Latest advances in computational genotoxicity prediction.
Naven RT; Greene N; Williams RV
Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1579-87. PubMed ID: 22998164
[TBL] [Abstract][Full Text] [Related]
50. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
51. Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities.
Contrera JF
Regul Toxicol Pharmacol; 2011 Feb; 59(1):133-41. PubMed ID: 20933038
[TBL] [Abstract][Full Text] [Related]
52. In silico methods combined with expert knowledge rule out mutagenic potential of pharmaceutical impurities: an industry survey.
Dobo KL; Greene N; Fred C; Glowienke S; Harvey JS; Hasselgren C; Jolly R; Kenyon MO; Munzner JB; Muster W; Neft R; Reddy MV; White AT; Weiner S
Regul Toxicol Pharmacol; 2012 Apr; 62(3):449-55. PubMed ID: 22321701
[TBL] [Abstract][Full Text] [Related]
53. SOS chromotest results in a broader context: empirical relationships between genotoxic potency, mutagenic potency, and carcinogenic potency.
White PA; Rasmussen JB
Environ Mol Mutagen; 1996; 27(4):270-305. PubMed ID: 8665872
[TBL] [Abstract][Full Text] [Related]
54. The importance of expert review to clarify ambiguous situations for (Q)SAR predictions under ICH M7.
Foster RS; Fowkes A; Cayley A; Thresher A; Werner AD; Barber CG; Kocks G; Tennant RE; Williams RV; Kane S; Stalford SA
Genes Environ; 2020; 42():27. PubMed ID: 32983286
[TBL] [Abstract][Full Text] [Related]
55. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins.
Kirkland D; Reeve L; Gatehouse D; Vanparys P
Mutat Res; 2011 Mar; 721(1):27-73. PubMed ID: 21238603
[TBL] [Abstract][Full Text] [Related]
56. Final report on the safety assessment of Glycyrrhetinic Acid, Potassium Glycyrrhetinate, Disodium Succinoyl Glycyrrhetinate, Glyceryl Glycyrrhetinate, Glycyrrhetinyl Stearate, Stearyl Glycyrrhetinate, Glycyrrhizic Acid, Ammonium Glycyrrhizate, Dipotassium Glycyrrhizate, Disodium Glycyrrhizate, Trisodium Glycyrrhizate, Methyl Glycyrrhizate, and Potassium Glycyrrhizinate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2007; 26 Suppl 2():79-112. PubMed ID: 17613133
[TBL] [Abstract][Full Text] [Related]
57. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development.
Dobo KL; Greene N; Cyr MO; Caron S; Ku WW
Regul Toxicol Pharmacol; 2006 Apr; 44(3):282-93. PubMed ID: 16464524
[TBL] [Abstract][Full Text] [Related]
58. Application of in vitro cell transformation assays in regulatory toxicology for pharmaceuticals, chemicals, food products and cosmetics.
Vanparys P; Corvi R; Aardema MJ; Gribaldo L; Hayashi M; Hoffmann S; Schechtman L
Mutat Res; 2012 Apr; 744(1):111-6. PubMed ID: 22342612
[TBL] [Abstract][Full Text] [Related]
59. Three new consensus QSAR models for the prediction of Ames genotoxicity.
Votano JR; Parham M; Hall LH; Kier LB; Oloff S; Tropsha A; Xie Q; Tong W
Mutagenesis; 2004 Sep; 19(5):365-77. PubMed ID: 15388809
[TBL] [Abstract][Full Text] [Related]
60. Bacterial mutagenicity test data: collection by the task force of the Japan pharmaceutical manufacturers association.
Hakura A; Awogi T; Shiragiku T; Ohigashi A; Yamamoto M; Kanasaki K; Oka H; Dewa Y; Ozawa S; Sakamoto K; Kato T; Yamamura E
Genes Environ; 2021 Sep; 43(1):41. PubMed ID: 34593056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
